OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+0.58%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.28%
AUM
$602M
AUM Growth
-$78.7M
(-12%)
Cap. Flow
-$53.2M
Cap. Flow
% of AUM
-8.84%
Top 10 Holdings %
Top 10 Hldgs %
57.8%
Holding
63
New
5
Increased
16
Reduced
14
Closed
15
Top Buys
| 1 |
Kiniksa Pharmaceuticals
KNSA
|
$11.6M |
| 2 |
Larimar Therapeutics
LRMR
|
$7.15M |
| 3 |
GeneDx Holdings
WGS
|
$5.24M |
| 4 |
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
|
$4.26M |
| 5 |
Keros Therapeutics
KROS
|
$3.29M |
Top Sells
| 1 |
AUTL
Autolus Therapeutics
AUTL
|
$12.1M |
| 2 |
Disc Medicine
IRON
|
$11M |
| 3 |
CKPT
Checkpoint Therapeutics
CKPT
|
$9.19M |
| 4 |
Immunovant
IMVT
|
$7.49M |
| 5 |
Sanara MedTech
SMTI
|
$7.01M |
Sector Composition
| 1 | Healthcare | 97.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCPH
26
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $7.52M | 1.25% |
205,381
-16,619
| -7% | -$608K |
|
|
27
Larimar Therapeutics
LRMR
$337M
| $7.15M | 1.19% |
+727,800
| New | +$7.15M |
|
28
TELA Bio
TELA
$65.4M
| $7.1M | 1.18% |
440,465
+75,465
| +21% | +$1.22M |
|
29
Seres Therapeutics
MCRB
$162M
| $5.96M | 0.99% |
12,500
-2,500
| -17% | -$1.19M |
|
|
SIOX
30
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $5.26M | 0.87% |
2,000,000
| – | – |
|
|
31
GeneDx Holdings
WGS
$3.65B
| $5.24M | 0.87% |
+11,328
| New | +$5.24M |
|
32
Avalo Therapeutics
AVTX
$139M
| $5.13M | 0.85% |
544
-359
| -40% | -$3.38M |
|
33
MEI Pharma
MEIP
$149M
| $4.46M | 0.74% |
78,250
+450
| +0.6% | +$25.6K |
|
|
AVEO
34
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $4.26M | 0.71% |
647,000
-188,000
| -23% | -$1.24M |
|
|
FMTX
35
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $4.26M | 0.71% |
+171,000
| New | +$4.26M |
|
|
LUMO
36
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $3.82M | 0.63% |
382,000
+5,100
| +1% | +$51K |
|
|
OPTN
37
DELISTED
OptiNose
OPTN
| $3.82M | 0.63% |
81,773
+26,706
| +48% | +$1.25M |
|
38
Kezar Life Sciences
KZR
$28.5M
| $3.79M | 0.63% |
69,780
-1,340
| -2% | -$72.8K |
|
39
Crinetics Pharmaceuticals
CRNX
$3.26B
| $3.78M | 0.63% |
200,500
+12,500
| +7% | +$236K |
|
|
APTO
40
DELISTED
Aptose Biosciences, Inc.
APTO
| $3.25M | 0.54% |
2,178
+241
| +12% | +$360K |
|
|
SRRA
41
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $3.22M | 0.54% |
165,500
+14,361
| +10% | +$280K |
|
42
Cardiff Oncology
CRDF
$130M
| $3.08M | 0.51% |
463,000
-113,000
| -20% | -$751K |
|
|
VIRX
43
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2.92M | 0.48% |
257,189
+153,589
| +148% | +$1.74M |
|
44
Pharvaris
PHVS
$1.41B
| $1.49M | 0.25% |
+79,837
| New | +$1.49M |
|
45
Leap Therapeutics
LPTX
$12M
| $886K | 0.15% |
54,000
+15,190
| +39% | +$249K |
|
|
CFRX
46
DELISTED
ContraFect Corporation
CFRX
| $255K | 0.04% |
724
-2,326
| -76% | -$819K |
|
47
Cidara Therapeutics
CDTX
$1.61B
| $148K | 0.02% |
+3,668
| New | +$148K |
|
|
BLRX
48
BioLineRX
BLRX
$15.5M
| $47K | 0.01% |
417
| – | – |
|
|
AUTL
49
Autolus Therapeutics
AUTL
$383M
| – | – |
-2,112,918
| Closed | -$12.1M |
|
|
CKPT
50
DELISTED
Checkpoint Therapeutics
CKPT
| – | – |
-292,596
| Closed | -$9.19M |
|